Trial
NCT03771885
BI 705564 in Patients With Systemic Lupus Erythematosus (SLE)
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Boehringer Ingelheim
Collaborators
—
Condition
Lupus Erythematosus, Systemic
Intervention
BI 705564
Why stopped
Based on a strategic decision, the application for the trial has been withdrawn before initiation.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-11-15